Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia (mesendo)

This study has been completed.
Information provided by:
TCA Cellular Therapy Identifier:
First received: August 16, 2007
Last updated: April 27, 2011
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)